Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)

Investigational Site Number : 1580001, Taipei

Investigational Site Number : 1580003, Tainan City

Investigational Site Number : 3480003, Budapest

Investigational Site Number : 0320004, CABA

Investigational Site Number : 0560001, Leuven

Investigational Site Number : 3480001, Debrecen

Investigational Site Number : 3480004, Székesfehérvár

Investigational Site Number : 0560002, Ghent

Investigational Site Number : 2760001, Berlin

Investigational Site Number : 2500005, Marseille

Altoona Center For Clinical Research Site Number : 8400001, Duncansville

Investigational Site Number : 4840002, Mexicali

Investigational Site Number : 7240002, Málaga

Investigational Site Number : 4840003, Chihuahua City

Omega Research Consultants Debary Site Number : 8400005, DeBary

Investigational Site Number : 1580005, Taoyuan

Investigational Site Number : 2500001, Montpellier

Ramesh C. Gupta, M.D. Site Number : 8400007, Memphis

Investigational Site Number : 1580002, Taichung

Investigational Site Number : 7240003, Seville

Investigational Site Number : 4840001, Monterrey

Investigational Site Number : 2500002, Strasbourg

Investigational Site Number : 2500004, Paris

Investigational Site Number : 2500006, Paris

Prolato Clinical Research Center Site Number : 8400009, Houston

Investigational Site Number : 2500003, Limoges

Investigational Site Number : 1520004, Viña del Mar

Investigational Site Number : 1520002, Osorno

Investigational Site Number : 1520001, Santiago

Investigational Site Number : 0320002, CABA

Investigational Site Number : 0320003, Pergamino

Investigational Site Number : 0320001, San Miguel de Tucumán

Investigational Site Number : 1240001, Sherbrooke

Investigational Site Number : 4100004, Daegu

Investigational Site Number : 4100002, Seoul

Investigational Site Number : 4100001, Seoul